Status:
COMPLETED
ERADICATING CERVICAL CANCER IN KENYA
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Moi University
Conditions:
Human Papilloma Virus
HIV Infections
Eligibility:
All Genders
9-60 years
Phase:
NA
Brief Summary
This is a study of a strategy designed to 1) increase cervical cancer screening using a community-based approach, and 2) determine the efficacy of HPV vaccination in a region of Kenya where half of al...
Detailed Description
Cervical cancer is caused by oncogenic HPV, and is the main cause of cancer-related death among Kenyan women. This malignancy is preventable through a combination of screening of adult women and vacci...
Eligibility Criteria
Inclusion
- Kenyan women between ages of 18 and 60 years and children/grandchildren aged 9 through 18 of women attending the Community Meetings.
Exclusion
- Pregnancy, history of cervical cancer, allergy to HPV vaccine (children)
- \-
Key Trial Info
Start Date :
November 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 18 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04774887
Start Date
November 13 2021
End Date
October 18 2023
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Webuye Clinic
Webuye, Kenya